Stockscreener 앱 받기
4.95
0.40%
-0.02
전일 마감가:
$4.97
열려 있는:
$4.96
하루 거래량:
1.31M
Relative Volume:
1.28
시가총액:
$259.07M
수익:
$44.12M
순이익/손실:
$-156.25M
주가수익비율:
-1.6124
EPS:
-3.07
순현금흐름:
$-154.61M
1주 성능:
+0.00%
1개월 성능:
+90.38%
6개월 성능:
+2.91%
1년 성능:
-1.20%
1일 변동 폭
$4.93
$4.96
1주일 범위
$4.93
$4.97
52주 변동 폭
$2.29
$5.90
2 Seventy Bio Inc Stock (TSVT) Company Profile
명칭
2 Seventy Bio Inc
전화
339-499-9300
주소
60 BINNEY STREET, CAMBRIDGE
TSVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSVT
2 Seventy Bio Inc
|
4.95 | 259.07M | 44.12M | -156.25M | -154.61M | -3.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-06 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-01-31 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-01-31 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-10-12 | 개시 | Citigroup | Buy |
| 2023-09-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-07-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-31 | 개시 | Guggenheim | Buy |
| 2022-05-02 | 개시 | Goldman | Buy |
| 2022-02-10 | 개시 | SVB Leerink | Outperform |
| 2022-01-06 | 개시 | Cowen | Outperform |
| 2021-11-09 | 개시 | Canaccord Genuity | Buy |
| 2021-11-08 | 개시 | Morgan Stanley | Overweight |
| 2021-11-08 | 개시 | Wedbush | Outperform |
모두보기
2 Seventy Bio Inc 주식(TSVT)의 최신 뉴스
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Charles Schwab Investment Management Inc. Has $1.26 Million Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
Bristol Meyers Squibb to Acquire 2seventy bio - Contract Pharma
2seventy bio, Inc. (NASDAQ:TSVT) Receives $7.20 Consensus PT from Analysts - Defense World
In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma - Fierce Pharma
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire
Rhumbline Advisers Has $249,000 Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
2Seventy Bio at TD Cowen Conference: Strategic Growth and Challenges - Investing.com
Analysts Set 2seventy bio, Inc. (NASDAQ:TSVT) Target Price at $7.20 - Defense World
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - Business Wire
Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH - Managed Healthcare Executive
Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World
Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
2 Seventy Bio Inc (TSVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2 Seventy Bio Inc 주식 (TSVT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Baird William D III | President and CEO |
Mar 17 '25 |
Sale |
4.95 |
5,092 |
25,180 |
1,121,034 |
| Eatwell Victoria | Chief Financial Officer |
Mar 17 '25 |
Sale |
4.95 |
2,592 |
12,817 |
444,387 |
| Kynam Global Healthcare Master | 10% Owner |
Mar 11 '25 |
Sale |
4.93 |
11,095,936 |
54,702,964 |
0 |
| Kynam Global Healthcare Master | 10% Owner |
Mar 11 '25 |
Sale |
4.93 |
5,142,111 |
25,350,607 |
0 |
| Snow Jessica | See Remarks |
Jan 06 '25 |
Sale |
2.79 |
5,114 |
14,289 |
147,365 |
| Snow Jessica | See Remarks |
Jan 03 '25 |
Sale |
2.94 |
1,000 |
2,936 |
152,479 |
| Snow Jessica | See Remarks |
Jan 07 '25 |
Sale |
2.64 |
186 |
491 |
147,179 |
| Leschly Nick | Director |
Jan 03 '25 |
Sale |
2.94 |
85,978 |
252,423 |
1,234,498 |
| Leschly Nick | Director |
Jan 06 '25 |
Sale |
2.78 |
892 |
2,478 |
1,233,606 |
| Eatwell Victoria | Chief Financial Officer |
Jan 03 '25 |
Sale |
2.94 |
1,013 |
2,974 |
339,076 |
3.01%
자본화:
|
볼륨(24시간):